Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 113130401000001110 | Lamivudine + Tenofovir disoproxil + Doravirine (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 113130501000001114 | Lamivudine + Tenofovir disoproxil + Doravirine | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lamivudine + Tenofovir disoproxil + Doravirine | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Lamivudine + Tenofovir disoproxil + Doravirine | Is a | Product containing lamivudine | false | Inferred relationship | Existential restriction modifier | ||
| Lamivudine + Tenofovir disoproxil + Doravirine | Is a | Product containing tenofovir | true | Inferred relationship | Existential restriction modifier | ||
| Lamivudine + Tenofovir disoproxil + Doravirine | Has active ingredient | Lamivudine | true | Inferred relationship | Existential restriction modifier | ||
| Lamivudine + Tenofovir disoproxil + Doravirine | Has active ingredient | Tenofovir | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets | Is a | True | Lamivudine + Tenofovir disoproxil + Doravirine | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR